(Q48963790)

17 February 2018

title

Neuropeptide degrading enzyme(s) in plasma and brain: Effects of in vivo neuroleptic administration (English)

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(82)80104-5

10 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(82)80104-5

10 August 2023

author name string

L. J. Traficante

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124980

10 August 2023

B. Turnbull

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6124980

10 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6124980

10 August 2023

publication date

1 April 1982

1 reference

17 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0031698982801045?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(82)80104-5

https://api.elsevier.com/content/article/PII:S0031698982801045?httpAccept=text/plain

10 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-6989(82)80104-5

Pharmacological research communications

10 August 2023

published in

1 reference

17 February 2018

volume

14

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

341-348

1 reference

17 February 2018

High-affinity enkephalin-degrading peptidase in brain is increased after morphine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Enkephalin inactivation by N-terminal tyrosine cleavage: purification and partial characterization of a highly specific enzyme from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

‘Enkephalinase’ is distinct from brain ‘angiostensin-converting enzyme’

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Monkey brain arylamidase. II. Further characterization and studies on mode of hydrolysis of physiologically active peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Localisation and characterisation of aminopeptidases in the CNS and the hydrolysis of enkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Enkephalin catabolism in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Inhibition of enkephalin-degrading enzymes from rat brain and of thermolysin by amino acid hydroxamates

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Plasma acth and cortisol levels in benzodiazepine treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0031-6989%2882%2980104-5

7 January 2021

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018